Sclerosis News and Research

RSS

A new kind of testing for patients with Parkinson's disease

Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.

26 Dec 2019

Research findings may one day help keep ALS at bay

A new study published in the journal Nature Medicine on December 23, 2019, shows how to silence a defective gene responsible for the degeneration of the motor neurons in Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), in adult mice. This could help prevent disease progression if the condition is already symptomatic, and even suppress the illness if it has not yet started.

23 Dec 2019

SLU researcher honored for finding better pain treatments

Researcher Daniela Salvemini, Ph.D., professor of pharmacology and physiology at Saint Louis University, has been named a Fellow of the National Academy of Inventors for her contributions toward understanding and finding better treatments for pain.

23 Dec 2019

Prospective memory associated with performance of everyday life activities in MS patients

Kessler Foundation researchers reported results of a study of deficits in prospective memory in individuals with multiple sclerosis (MS) that may contribute to difficulties with everyday life activities.

22 Dec 2019

Could high cholesterol lead to motor neuron disease?

Researchers suggest that motor neuron disease may be linked to an abnormal build-up of cholesterol and other lipids within cellular compartments.

20 Dec 2019

Obesity, but not poor diet and lack of exercise, associated with higher dementia risk

A large study that followed more than one million women for nearly two decades has found that obesity in midlife is linked to a greater risk of dementia later in life; however, poor diet and lack of exercise are not.

18 Dec 2019

New standards needed for improving the design of clinical trials for MS patients

How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was investigated and corresponding recommendations were developed by a working group of the Drug Commission of the German Medical Association, the Charité University Hospital Berlin, and the Institute for Quality and Efficiency in Health Care.

17 Dec 2019

Cancer drug shows promise in battling Parkinson’s disease

Parkinson’s disease (PD) is a lifelong condition that affects the nerve cells in the brain that produce dopamine. As a result, people with this neurodegenerative disease experience tremors, changes in speech, gait issues, and muscle rigidity. Though it has no cure, a new drug used to treat cancer shows promise in treating Parkinson’s.

17 Dec 2019

Study shows how immune cells quickly switch to attack mode

Macrophages have two faces: In healthy tissue, they perform important tasks and support their environment. However during an infection, they stop this work and hunt down the pathogens instead.

17 Dec 2019

Study finds new drivers of destructive inflammation

Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases.

17 Dec 2019

New line of wearable robotics could keep seniors on their feet longer

A new line of wearable robotics developed by The University of Texas Health Science Center at Houston (UTHealth) and The City University of New York, City College (CCNY) could keep seniors on their feet longer.

17 Dec 2019

Researchers identify factors impacting money management skills in MS patients

A team of rehabilitation researchers identified factors associated with the money management problems experienced by some individuals with multiple sclerosis.

17 Dec 2019

Researchers demonstrate a novel method for treating multiple sclerosis

Measuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to researchers at the University of Wisconsin–Madison, and could be used to evaluate new treatments for the disease.

17 Dec 2019

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

The results of a study conducted in Brazil suggest that the sympathetic nervous system - the part of the autonomous nervous system that controls responses to danger or stress - can modulate the action of defense cells in patients with autoimmune diseases.

16 Dec 2019

Taking long midday naps or sleeping nine or more hours at night may increase stroke risk

People who take long naps during the day or sleep nine or more hours at night may have an increased risk of stroke, according to a study published in the December 11, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Dec 2019

UCLA scientists discover reason for higher rates of autoimmune disease in women than men

UCLA scientists have discovered one reason why autoimmune diseases are more prevalent in women than in men.

11 Dec 2019

Study finds irregular brain function in children with Type 1 diabetes

Children with Type 1 diabetes show subtle but important differences in brain function compared with those who don't have the disease, a study led by researchers at the Stanford University School of Medicine has shown.

10 Dec 2019

New study uncovers the genetic basis of memory

New research has uncovered the genetic basis for different functions of memory.

10 Dec 2019

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.

8 Dec 2019

The role of adenosine in neurodegeneration and brain regeneration

The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis.

8 Dec 2019